The page is the record's research on the issuer — no analyst, no rating, no view.

# Cue Biopharma, Inc. (NASDAQ: CUE) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

Cue Biopharma, Inc. is listed on NASDAQ under the ticker CUE, with ISIN US22978P2056 and LEI 549300PBW78KZA33WC97. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its segment is not on the record. Its listing status is listed, not halted.

## The disclosure read

The record holds 101 filings in the twelve months to 2026-11-08, across 54 filing days. The median gap between filing days is 4 days. The days from the latest filing to the record date is 25 days. The latest filing is a directors_dealings filing dated 2026-10-14. The NASDAQ exchange median is 52 filings, a cadence gap of 6.0 days, and a latency of 5.0 days. The 2834 Pharmaceutical Preparations sector median is 63.0 filings, a cadence gap of 6.0 days, and a latency of 4.0 days.

## Auditor

The auditor of record is RSM US LLP, located in Boston, Massachusetts. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations page.

## Open research

No openly published research notes were found.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer is sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- https://data.sec.gov/submissions/CIK0001645460.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/CUE (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1645460/000119312526108287/cue-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/CUE (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CUE · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp